Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Liver Neoplasms 2Carcinoma 2

Interventions

Sorafenib 12Radiosurgery 5Gemcitabine 5Capecitabine 5Bevacizumab 5Radiotherapy 4Fluorouracil 4Doxorubicin 4Sunitinib 3Oxaliplatin 3Nivolumab 3Magnetic Resonance Spectroscopy 3seocalcitol 2regorafenib 2phosphomannopentaose sulfate 2atezolizumab 2Thiotepa 2Radiofrequency Ablation 2Melphalan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Fluorodeoxyglucose F18 2Filgrastim 2Dexamethasone 2Cisplatin 2Chemoembolization, Therapeutic 2Carboplatin 2Busulfan 2Brachytherapy 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Liver Neoplasms × seocalcitol × Clear all
NCT00051532 2025-02-25

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

LEO Pharma

Phase NA Terminated
700 enrolled
Gastrointestinal

Carcinoma, Liver Neoplasms, Neoplasms

NCT00051545 2025-02-25

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

LEO Pharma

Phase 3 Terminated
608 enrolled
Gastrointestinal

Carcinoma, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡